Malaria Industry 2026

View Trends, Analysis and Statistics.

1 000+ Malaria Industry reports covering 200 countries — revenue data, market shares and forecast 2026-2030.

African Malaria Industry 2026‑2030

  • 400+ reports

  • Malaria Treatment Coverage, Malaria Incidence…
  • 200+ statistics

  • Malaria Treatment Coverage, Malaria Prevalence, Malaria Prevention Coverage, Malaria Incidence…

Global Malaria Industry 2026‑2030

Global malaria market to reach $1.2B by 2030 at 4.9% CAGR. Novartis, GSK, Cipla and Ipca lead the global competitive field. Prevalence, treatment & mortality forecasts by region, 2026-2030.

Sub-Saharan African Malaria Industry 2026‑2030

  • 300+ reports

  • Malaria Prevention Coverage, Malaria Prevalence, Malaria Treatment Coverage…
  • 200+ statistics

  • Malaria Mortality, Malaria Incidence, Malaria Treatment Coverage…

East African Malaria Industry 2026‑2030

  • 100+ reports

  • Malaria Mortality, Malaria Treatment Coverage…
  • 80+ statistics

  • Malaria Incidence, Malaria Prevalence, Malaria Prevention Coverage, Malaria Treatment Coverage…

Asian Malaria Industry 2026‑2030

Asia malaria market to exceed $780M by 2030 at 5.1% CAGR. Key players include Cipla, Ipca Laboratories, Novartis and Ajanta Pharma. Incidence, mortality & treatment coverage data with 2026-2030 forecasts.

West African Malaria Industry 2026‑2030

  • 100+ reports

  • Malaria Incidence, Malaria Mortality, Malaria Prevalence, Malaria Treatment Coverage…
  • 80+ statistics

  • Malaria Mortality, Malaria Treatment Coverage, Malaria Incidence, Malaria Prevention Coverage…

Southeast Asian Malaria Industry 2026‑2030

  • 60+ reports

  • Malaria Prevention Coverage, Malaria Incidence, Malaria Prevalence, Malaria Mortality…
  • 60+ statistics

  • Malaria Incidence, Malaria Mortality, Malaria Treatment Coverage, Malaria Prevention Coverage…

North American Malaria Industry 2026‑2030

North America malaria market growing at 4.2% CAGR to 2030. GSK, Novartis and 60 Degrees Pharma lead regional supply. Treatment, prevention & prevalence forecasts, 2026-2030.

Any questions? Get in touch with Emilie

+33 4 37 65 17 06

+61 280 114 871

+1 718 303 2384

+852 8199 0067

+44 207 193 2091

+44 207 193 2091

ReportLinker Rating

96%

of our customers give us a high rating on Trustpilot and G2 platforms